Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 119
Filtrar
Más filtros

Intervalo de año de publicación
1.
Eur J Health Econ ; 22(9): 1349-1363, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34019220

RESUMEN

OBJECTIVES: To assess the cost-effectiveness (CE) of transcatheter aortic valve implantation (TAVI) in Italy, considering patient groups with different surgical risk. METHODS: A Markov model with a 1-month cycle length, comprising eight different health states, defined by the New York Heart Association functional classes (NYHA I-IV), with and without stroke plus death, was used to estimate the CE of TAVI for intermediate-, high-risk and inoperable patients considering surgical aortic valve replacement or medical treatment as comparators according to the patient group. The Italian National Health System perspective and 15-year time horizon were considered. In the base-case analysis, effectiveness data were retrieved from published efficacy data and total direct costs (euros) were estimated from national tariffs. A scenario analysis considering a micro-costing approach to estimate procedural costs was also considered. The incremental cost-effectiveness ratio (ICER) was expressed both in terms of costs per life years gained (LYG) and costs per quality adjusted life years (QALY). All outcomes and costs were discounted at 3% per annum. Univariate and probabilistic sensitivity analyses (PSA) were performed to assess robustness of results. RESULTS: Over a 15-year time horizon, the higher acquisition costs for TAVI were partially offset in all risk groups because of its effectiveness and safety profile. ICERs were €8338/QALY, €11,209/QALY and €10,133/QALY, respectively, for intermediate-, high-risk and inoperable patients. ICER values were slightly higher in the scenario analysis. PSA suggested consistency of results. CONCLUSIONS: TAVI would be considered cost-effective at frequently cited willingness-to-pay thresholds; further studies could clarify the CE of TAVI in real-life scenarios.


Asunto(s)
Estenosis de la Válvula Aórtica , Implantación de Prótesis de Válvulas Cardíacas , Reemplazo de la Válvula Aórtica Transcatéter , Estenosis de la Válvula Aórtica/cirugía , Análisis Costo-Beneficio , Humanos , Italia , Años de Vida Ajustados por Calidad de Vida , Resultado del Tratamiento
2.
Science ; 263(5143): 92-5, 1994 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-8272873

RESUMEN

A recently defined family of cytokines, consisting of ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), and interleukin-6 (IL-6), utilize the Jak-Tyk family of cytoplasmic tyrosine kinases. The beta receptor components for this cytokine family, gp130 and LIF receptor beta, constitutively associate with Jak-Tyk kinases. Activation of these kinases occurs as a result of ligand-induced dimerization of the receptor beta components. Unlike other cytokine receptors studied to date, the receptors for the CNTF cytokine family utilize all known members of the Jak-Tyk family, but induce distinct patterns of Jak-Tyk phosphorylation in different cell lines.


Asunto(s)
Antígenos CD , Citocinas/farmacología , Inhibidores de Crecimiento , Interleucina-6 , Linfocinas , Glicoproteínas de Membrana/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas , Receptores de Citocinas/metabolismo , Animales , Línea Celular , Factor Neurotrófico Ciliar , Receptor gp130 de Citocinas , Citocinas/metabolismo , Activación Enzimática , Janus Quinasa 1 , Janus Quinasa 2 , Factor Inhibidor de Leucemia , Proteínas del Tejido Nervioso/metabolismo , Proteínas del Tejido Nervioso/farmacología , Oncostatina M , Péptidos/metabolismo , Péptidos/farmacología , Fosforilación , Proteínas/metabolismo , Receptor de Factor Neurotrófico Ciliar , Receptores de Factores de Crecimiento/metabolismo , Receptores de Interleucina/metabolismo , Receptores de Interleucina-6 , Receptores OSM-LIF , Receptores de Oncostatina M , Tirosina/metabolismo
3.
Data Brief ; 25: 104250, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31497628

RESUMEN

Data on this paper describe the monitoring of different size ranges of particulate matter on dwellings positioned close to an integral cycle steel plant. Data were collected by eight channel (PM0.3, PM0.5, PM0.7, PM1, PM2, PM3, PM5, PM10) optical particle counters positioned in two sites. The data were recorded as counts-per-minute for every size channel in a three months survey from June to September 2015. Basic statistical elaboration and boxplot graphs as well as raw data are included. The data are related to "Characterization of variability of air particulate matter size profiles recorded by Optical Particle Counters near a complex emissive source by use of Self-Organizing Map algorithm" Licen et al.,2019, in which a statistical elaboration by Self-Organizing Map algorithm is proposed.

4.
Meat Sci ; 80(4): 1132-7, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22063848

RESUMEN

Protein composition was examined in order to find markers that could be useful in technology optimization. The behaviour of sarcoplasmic and myofibrillar proteins during the processing of roast pork was studied at the various processing steps, utilising some electrophoretic (SDS-PAGE, 2DE and IEF) and thermometric (DSC) techniques and evaluating the content of amino acids produced. The relevance of desmin as a marker of structural modification was emphasised. The extraction of myofibrillar proteins by brine, the formation of a protein network at 62°C and the evaluation of the exudate produced during cooking are the crucial steps that should be monitored when a new industrial process is to be optimised.

5.
Leukemia ; 32(2): 438-449, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28745329

RESUMEN

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by hyperplastic megakaryopoiesis and myelofibrosis. We recently described the upregulation of MAF (v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog) in PMF CD34+ hematopoietic progenitor cells (HPCs) compared to healthy donor. Here we demonstrated that MAF is also upregulated in PMF compared with the essential thrombocytemia (ET) and polycytemia vera (PV) HPCs. MAF overexpression and knockdown experiments shed some light into the role of MAF in PMF pathogenesis, by demonstrating that MAF favors the megakaryocyte and monocyte/macrophage commitment of HPCs and leads to the increased expression of proinflammatory and profibrotic mediators. Among them, we focused our further studies on SPP1 and LGALS3. We assessed SPP1 and LGALS3 protein levels in 115 PMF, 47 ET and 24 PV patients plasma samples and we found that SPP1 plasma levels are significantly higher in PMF compared with ET and PV patients. Furthermore, in vitro assays demonstrated that SPP1 promotes fibroblasts and mesenchymal stromal cells proliferation and collagen production. Strikingly, clinical correlation analyses uncovered that higher SPP1 plasma levels in PMF patients correlate with a more severe fibrosis degree and a shorter overall survival. Collectively our data unveil that MAF overexpression contributes to PMF pathogenesis by driving the deranged production of the profibrotic mediator SPP1.


Asunto(s)
Médula Ósea/metabolismo , Médula Ósea/patología , Fibrosis/metabolismo , Fibrosis/patología , Osteopontina/metabolismo , Proteínas Proto-Oncogénicas c-maf/metabolismo , Antígenos CD34/metabolismo , Proliferación Celular/fisiología , Células Madre Hematopoyéticas/metabolismo , Células Madre Hematopoyéticas/patología , Humanos , Megacariocitos/metabolismo , Megacariocitos/patología , Trastornos Mieloproliferativos/metabolismo , Trastornos Mieloproliferativos/patología , Policitemia Vera/metabolismo , Policitemia Vera/patología , Mielofibrosis Primaria/metabolismo , Mielofibrosis Primaria/patología , Trombocitemia Esencial/metabolismo , Trombocitemia Esencial/patología
6.
Mol Cell Biol ; 15(11): 5991-6002, 1995 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7565752

RESUMEN

To provide evidence for the cis-regulatory DNA sequences and trans-acting factors involved in the complex pattern of tissue- and stage-specific expression of the beta enolase gene, constructs containing fragments of the gene fused to the chloramphenicol acetyltransferase gene were used in transient-transfection assays of C2C12 myogenic cells. Deletion analysis revealed the presence of four major regions: two negative regions in the 5'-flanking sequence, a basal promoter region which directs expression at low levels in proliferating and differentiated muscle cells, and a positive region within the first intron that confers cell-type-specific and differentiation-induced expression. This positive regulatory element is located in the 3'-proximal portion of the first intron (nucleotides +504 to +637) and acts as an enhancer irrespective of orientation and position from the homologous beta enolase promoter or the heterologous thymidine kinase promoter, conferring in both cases muscle-specific expression to the linked reporter gene. Deletion of a putative myocyte-specific enhancer factor 1 (MEF-1) binding site, containing a canonical E-box motif, had no effects on muscle-specific transcription, indicating that this site is not required for the activity of the enhancer. Gel mobility shift assays, competition analysis, DNase I footprinting, and mutagenesis studies indicated that this element interacts through an A/T-rich box with a MEF-2 protein(s) and through a G-rich box with a novel ubiquitous factor(s). Mutation of either the G-rich box or the A/T-rich box resulted in a significantly reduced activity of the enhancer in transient-transfection assays. These data indicate that MEF-2 and G-rich-box binding factors are each necessary for tissue-specific expression of the beta enolase gene in skeletal muscle cells.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Elementos de Facilitación Genéticos , Intrones , Músculos/enzimología , Fosfopiruvato Hidratasa/genética , Factores de Transcripción/metabolismo , Animales , Secuencia de Bases , Sitios de Unión , Expresión Génica , Humanos , Factores de Transcripción MEF2 , Ratones , Datos de Secuencia Molecular , Factores Reguladores Miogénicos , Oligodesoxirribonucleótidos/química , ARN Mensajero/genética , Ratas , Alineación de Secuencia , Homología de Secuencia de Ácido Nucleico , Transcripción Genética
7.
Gait Posture ; 26(4): 603-6, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17257846

RESUMEN

The purpose of this study was to develop and validate a new tool to objectively quantify trunk orientation at the bedside, especially dedicated to the measurement of the lateropulsion in acute and subacute stroke patients. We developed software to analyze 2D movement with a CMOS camera (Logitech Quickcam Pro 4000) and to calculate the orientation of a segment defined by two color markers. First, the accuracy, reproducibility and noise when measuring segment orientations were evaluated with the CMOS camera placed in different positions, and second trunk orientation was measured in static and in dynamic conditions both with a CMOS camera and with a gold standard 3D video system (BTS SMART-e). Results showed that the measurement was accurate (mean error=0.05+/-0.12 degrees), reproducible (S.D. over five measurements=0.005 degrees ) and steady (noise signal=0.02 degrees ). The data obtained with the CMOS camera were highly correlated with those obtained with the 3D video system both in static and in dynamic conditions. However, the CMOS camera must be relatively well centered on the measured segment to avoid error due to image distortion. The parallax error was negligible. In conclusion, this could be an important step in the postural assessment of acute and subacute stroke patients. The CMOS camera, a simple, portable, compact, low-cost, commercially available apparatus is the first tool to objectively quantify lateropulsion at the bedside. This method could also support the development of a rehabilitation program for trunk orientation based on biofeedback using the real-time signal provided by the device.


Asunto(s)
Procesamiento de Imagen Asistido por Computador/instrumentación , Postura/fisiología , Accidente Cerebrovascular/fisiopatología , Tórax/fisiología , Grabación de Cinta de Video/instrumentación , Algoritmos , Estudios de Factibilidad , Humanos , Reproducibilidad de los Resultados , Programas Informáticos
8.
J Biotechnol ; 117(3): 309-21, 2005 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-15862362

RESUMEN

For an efficient membrane bioreactor design, transport phenomena determining the overall mass flux of metabolites, catabolites, cell regulatory factors, and immune-related soluble factors, need to be clarified both experimentally and theoretically. In this work, experiments and calculations aimed at discerning the simultaneous influence of both diffusive and convective mechanisms to the transport of metabolites. In particular, the transmembrane mass flux of glucose, bovine serum albumin (BSA), APO-transferrin, immunoglobulin G, and ammonia was experimentally measured, under pressure and concentration gradients, through high-flux microporous hydrophilic poly-ether-sulphone (PES-HFMs) and poly-sulphone hollow fiber membranes (PS-HFMs). These data were analyzed by means of a model based on the mechanism of capillary pore diffusion, assuming that solute spherical molecules pass through an array of solvent-filled cylindrical pores with a diffusive permeation corrected for friction and steric hindrances. Additionally, resistances to the mass transfer were taken into account. Convective permeation data were discussed in terms of morphological properties of the polymeric membranes, molecular Stokes radius, and solute-membrane interactions according to information given by contact angle measurements. The observed steady-state hydraulic permeance of PS-HFMs was 0.972 L/m2hmbar, about 15.6-fold lower than that measured for PES-HFMs (15.2 L/m2h); in general, PS-HFMs provided a significant hindrance to the transport of target species. Diffusion coefficients of metabolites were found to be similar to the corresponding values in water through PES-HFMs, but significantly reduced through PS-HFMs (D(Glucose)(Membrane)=2.8x10(-6)+/-0.6x10(-6)cm2/s, D(BSA)(Membrane)=6.4 x 10(-7)+/-1 x 10(-7)cm(/s, D(Apotransferrin)(Membrane)=2.3 x 10(-7)+/-0.25 x 10(-7)cm2/s).


Asunto(s)
Transporte Biológico , Hepatocitos/citología , Hepatocitos/metabolismo , Hígado/citología , Membranas Artificiales , Amoníaco/análisis , Animales , Apoenzimas/análisis , Fenómenos Biofísicos , Biofisica , Bovinos , Técnicas de Cultivo de Célula , Células Cultivadas , Difusión , Glucosa/análisis , Humanos , Inmunoglobulina G/análisis , Microscopía Electrónica de Rastreo , Polímeros/química , Porosidad , Albúmina Sérica Bovina/análisis , Sulfonas/química , Tromboplastina/análisis
9.
Leukemia ; 18(4): 832-40, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-14973505

RESUMEN

Loss of MHC class II expression in B-cell lymphoma has been associated with a higher tumorigenicity resulting from lower titers of tumor-infiltrating lymphocytes. This report aims towards the identification of the molecular mechanism leading to defective MHC class II expression in a B-cell lymphoma cell line, Rec-1. We evidenced a coordinated alteration of HLA-D gene transcription, reminiscent of B lymphoblastoid cell lines from patients with MHC class II deficiency. Genetic complementation performed between these cell lines and the lymphoma cells indicated that Rec-1 is altered in the MHC2TA gene. MHC2TA encodes the class II transactivator (CIITA), the master regulator of HLA-D gene expression. However, the coding sequence of the Rec-1 CIITA transcript did not reveal any mutation that could hamper the activity of the encoded protein. In agreement with the genetic complementation analysis, we evidenced a highly residual CIITA protein expression in the Rec-1 cell line resulting from a transcriptional defect affecting MHC2TA expression. Anti-HLA-DR monoclonal antibody treatment has proved efficient in the destruction of B lymphoma cells. Our data indicate that the appearance of variants losing CIITA, and thereby HLA-DR, expression will require a thorough monitoring during such immunotherapy protocols.


Asunto(s)
Genes MHC Clase II , Linfoma de Células B/patología , Proteínas Nucleares/genética , Transactivadores/genética , Línea Celular Tumoral , Análisis Mutacional de ADN , ADN Complementario , Regulación Neoplásica de la Expresión Génica , Prueba de Complementación Genética , Antígenos HLA-D/genética , Humanos , Linfoma de Células B/genética , Masculino , Persona de Mediana Edad , Mutación , Transcripción Genética
10.
J Cereb Blood Flow Metab ; 7(6): 806-11, 1987 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-3121648

RESUMEN

The effects of an anesthetic dose (100 mg/kg) of ketamine, a phencyclidine derivative, on local rates of cerebral glucose utilization (LCGU) and CBF (LCBF) have been investigated by the quantitative [14C]2-deoxy-glucose and [14C]iodoantipyrine techniques in the unparalyzed, spontaneously breathing rat. In ketamine-injected animals, LCGU was significantly increased in some limbic structures and decreased in inferior colliculus, vestibular, and cerebellar nuclei. The degree and spatial distribution of drug-induced changes was similar for local blood flow rates, LCBF being increased in limbic regions and decreased in the inferior colliculus. Although Paco2 values were higher in anesthetized animals, the pattern of LCBF/LCGU ratios was not significantly affected by ketamine in the 36 brain regions examined in this study. So, at least in the rat and at the anesthetic level studied here, a net vasodilatory in vivo effect was not observed. These results support the hypothesis that CBF changes induced by the drug in animals and man are primarily related to the metabolic effects exerted by ketamine on cerebral structures.


Asunto(s)
Encéfalo/metabolismo , Circulación Cerebrovascular/efectos de los fármacos , Desoxiazúcares/metabolismo , Desoxiglucosa/metabolismo , Ketamina/farmacología , Animales , Sangre , Velocidad del Flujo Sanguíneo , Presión Sanguínea , Encéfalo/efectos de los fármacos , Dióxido de Carbono/sangre , Concentración de Iones de Hidrógeno , Masculino , Oxígeno/sangre , Ratas , Distribución Tisular
11.
Gene ; 79(2): 355-60, 1989 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-2792767

RESUMEN

The nucleotide sequence of the human gamma-enolase mRNA was determined from recombinant cDNA clones. The sequence spans 2273 bp and includes the complete coding region of 1299 bp, a 5'-noncoding region of 74 bp and a 897-bp-long 3'-noncoding region containing a variant polyadenylation signal (ATTAAA). The deduced amino acid (aa) sequence is 433 aa long and shows a 97% similarity with rat gamma-enolase. Both the 5'- and 3'-untranslated regions are similar (82% and 68%, respectively) to the analogous regions of the rat gamma-enolase gene, suggesting that a strong selective pressure operates on noncoding segments of gamma-enolase mRNAs. The size of the gamma-enolase mRNA expressed in human brain is 2.4 kb. A crosshybridizing 1.5-kb message is detected in human skeletal muscle which may be derived from the beta-enolase-coding gene.


Asunto(s)
Clonación Molecular , ADN/genética , Fosfopiruvato Hidratasa/genética , ARN Mensajero/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Sondas de ADN , Humanos , Datos de Secuencia Molecular , Especificidad de Órganos , Ratas , Mapeo Restrictivo , Homología de Secuencia de Ácido Nucleico
12.
Neuroscience ; 41(2-3): 655-65, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1870703

RESUMEN

The functional activity pattern in the cervical enlargement of the spinal cord (as expressed by changes in local glucose utilization) was investigated by the semi-quantitative [14C]2-deoxyglucose technique 2 min ("early" group) or 60 min ("late" group) after injection of a small amount of dilute formalin (0.06-0.08 ml, 5%) in a forepaw of unanesthetized, freely-moving rats. Control animals were either injected with an equivalent volume of saline or simply handled. In both formalin groups a tonic flexion of the injected limb was present during the experiments, while supraspinal-integrated behavior (such as licking the affected paw) was sharply reduced in the late group. A bilateral increase of metabolic activity indexes, more pronounced on the ipsilateral side, was found in the "early" formalin-injected animals. The highest increase over control values was found in the medial part of the superficial (laminae I-II) region of the ipsilateral dorsal horn. However, the [14C]2-deoxyglucose uptake was found to be elevated over the whole extent of the dorsal horns, as well as in the gray matter surrounding the central canal, anterior horns and ipsilateral dorsolateral funiculus. In a parallel group of experiments performed in pentobarbital-anesthetized rats metabolic increases in the early period after formalin injection were less pronounced; they were only found in the ipsilateral side of the cord. In the "late" formalin group the overall metabolic changes were less conspicuous. They were mainly observed in the side ipsilateral to the injection, the highest increase being found in the deep portion (laminae V-VI) of the dorsal horn. Therefore, the spatial distribution of functional activation elicited during prolonged noxious stimulation in the spinal cord gray matter of unanesthetized rats varies according to time and changes in animal behavior.


Asunto(s)
Desoxiglucosa/metabolismo , Formaldehído/farmacología , Médula Espinal/fisiología , Animales , Autorradiografía , Glucemia/metabolismo , Presión Sanguínea/efectos de los fármacos , Radioisótopos de Carbono , Masculino , Ratas , Ratas Endogámicas , Valores de Referencia , Médula Espinal/anatomía & histología , Médula Espinal/efectos de los fármacos
13.
Am J Kidney Dis ; 33(4): 702-8, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10196012

RESUMEN

The prevalence of pulmonary thromboembolism at autopsy was assessed in a retrospective study of a cohort of 185 patients undergoing maintenance hemodialysis treatment who died in the last decade. The overall frequency of thromboembolism was 12.43% in the dialysis population, which statistically was significantly less than in a control group of 8,051 nondialysis patients (21.77%; P = 0.0023). Moreover, pulmonary thromboembolism was less frequently fatal or contributing to death in the dialysis group than in the control group (P = 0.039). The prevalence of pulmonary thromboembolism in the dialysis group remained statistically unchanged over the 10-year period and was independent of a steady increase in the percentage of patients receiving recombinant erythropoietin therapy and the average hematocrit values. The occurrence of preterminal pulmonary thromboembolism was associated with a shorter period since onset of hemodialysis treatment and with infection as cause of death (P = 0. 031; P = 0.029, respectively). No statistically significant influence of the type of basic renal disease, type of dialysis anticoagulation, or dialysis access could be found. Our data suggest that, at least in the preterminal stage, the introduction of recombinant erythropoietin within the last decade had no substantial influence on the prevalence of pulmonary thromboembolism.


Asunto(s)
Eritropoyetina/uso terapéutico , Embolia Pulmonar/epidemiología , Embolia Pulmonar/prevención & control , Diálisis Renal , Anciano , Causas de Muerte , Estudios de Cohortes , Femenino , Humanos , Masculino , Prevalencia , Proteínas Recombinantes , Estudios Retrospectivos
14.
Leuk Res ; 24(7): 583-7, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10867132

RESUMEN

The efficacy of continuous oral cytarabine ocfosfate (YNK01) (300 mg/day) in combination with interferon alpha (IFNalpha, 5x10(6) IU/day) was evaluated in patients with advanced chronic myelogenous leukemia, who previously failed to respond to IFNalpha-based therapies. Dose escalations up to 900 mg YNK01 were allowed in patients who failed to respond. In view of our results, four patients developed a complete hematological response after YNK01 was started. Among those who initially responded to YNK01, one complete cytogenetic response was achieved 18 months later. Although the data are preliminary, this is the first study showing that continuous administration of YNK01 along with IFNalpha is effective in patients with advanced chronic myelogenous leukemia.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Arabinonucleotidos/uso terapéutico , Citidina Monofosfato/análogos & derivados , Citidina Monofosfato/uso terapéutico , Interferón-alfa/uso terapéutico , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Arabinonucleotidos/administración & dosificación , Arabinonucleotidos/efectos adversos , Citidina Monofosfato/administración & dosificación , Citidina Monofosfato/efectos adversos , Humanos , Interferón alfa-2 , Interferón-alfa/administración & dosificación , Interferón-alfa/efectos adversos , Persona de Mediana Edad , Proyectos Piloto , Proteínas Recombinantes , Resultado del Tratamiento
15.
Drug Alcohol Depend ; 15(4): 361-6, 1985 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-4053973

RESUMEN

The hypothalamus-pituitary-adrenal axis of heroin addicts was investigated by evaluating plasma cortisol levels throughout the day in 37 heroin abusers (HA), 17 of whom showed detectable morphine levels, indicating heroin administration in the previous hours and in 12 controls. All HA showed lower cortisol levels in basal condition (100.7 +/- 61.7 ng/ml, M +/- S.D.) compared to the control group (159.7 +/- 40.6, P less than 0.05). Moreover all HA (65.1 +/- 28.9%), and in particular those taking heroin during the study (39.1 +/- 41.4%), show a reduced cortisol decrease in the evening, which was significantly lower than in controls (85.3 +/- 10.1%; P less than 0.01). As far as the acute effects of opiates are concerned morphine (0.1 mg/kg) significantly reduced plasma cortisol levels within 60 min in a group of 8 healthy subjects. The same pattern was displayed by only 3/8 HA whose morphine levels were higher than 1 ng/ml, i.e. in those reaching the highest plasma morphine concentrations. These data indicate that chronic opiate abuse leads to a hypoadrenalism which could be the result of morphine-induced changes at the hypothalamic level.


Asunto(s)
Dependencia de Heroína/fisiopatología , Sistema Hipotálamo-Hipofisario/fisiopatología , Sistema Hipófiso-Suprarrenal/fisiopatología , Adolescente , Adulto , Ritmo Circadiano , Femenino , Humanos , Hidrocortisona/sangre , Masculino , Morfina/sangre
16.
Life Sci ; 38(23): 2103-10, 1986 Jun 09.
Artículo en Inglés | MEDLINE | ID: mdl-3086650

RESUMEN

A number of studies have been made on the role played by endogenous opioid peptides in the secretion of LH in humans. However no previous studies have compared the effects of the most potent pharmacological agonist and antagonist, morphine and naloxone, in the same subjects. The present study examined the acute effects of injections of morphine and naloxone on plasma LH levels in 30 healthy subjects (18 women and 12 men). Fertile women were subdivided into follicular (n = 6) and luteal (n = 6) phase groups; the remaining 6 were postmenopausal women. The 12 men were sub-divided in two groups of 6 subjects according to age (24-33 years, and over 60 years). There was a two day interval between injection studies in the same subjects. Morphine significantly decreased plasma LH levels in all groups examined (P less than 0.01). On the other hand, naloxone caused a significant increase in plasma LH levels in fertile women during the luteal phase of the cycle, but not during the follicular phase or in postmenopausal subjects, and in young but not in aged men (P less than 0.01). These results indicate that in humans there is a change in the activity of the opioids regulating LH secretion during the menstrual cycle, after menopause and in aged men and that these may be studied by the use of naloxone. The inability of naloxone under certain conditions to increase LH levels reflects the decreased activity of the endogenous system, while morphine, being active in all the subjects, seems to be less discriminative, at least in physiological conditions.


Asunto(s)
Envejecimiento , Hormona Luteinizante/sangre , Menopausia , Ciclo Menstrual , Morfina/farmacología , Naloxona/farmacología , Adulto , Anciano , Estradiol/sangre , Femenino , Hormona Folículo Estimulante/sangre , Humanos , Masculino , Persona de Mediana Edad , Progesterona/sangre , Prolactina/sangre , Factores de Tiempo
17.
Life Sci ; 41(23): 2581-8, 1987 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-2960867

RESUMEN

There is growing experimental evidence that beta-endorphin immunoreactivity is raised by surgical stress in patients undergoing general anesthesia. As the assay methods employed to date did not allow to fully discriminate between beta-endorphin and its immediate precursor, beta-lipotropin, we have investigated in the present study plasma levels of these two peptides by separating them by chromatography on plasma extracts prior to radioimmunoassay in eighteen surgical patients under general anesthesia and eight under spinal anesthesia. Beta-lipotropin, but not beta-endorphin, plasma levels were found to be significantly elevated during surgery in the general anesthesia group, while no change was found in either peptide concentration in the spinal one. Cortisol plasma levels also increased significantly 90 minutes after the beginning of surgery, when they were positively correlated to beta-lipotropin ones. Although the sampling time we adopted may have prevented us from detecting an early peak of beta-endorphin during the first 30 minutes of surgery, the major component of the pituitary opioid response to surgical stress appears to be related to beta-lipotropin. This is in agreement with results of experimental work on various kinds of stress in animals and humans and seems to rule out a role for plasma beta-endorphin in post-operative analgesia.


Asunto(s)
Procedimientos Quirúrgicos Operativos , betaendorfina/sangre , beta-Lipotropina/sangre , Adulto , Anestesia General , Anestesia Raquidea , Animales , Cromatografía en Gel , Femenino , Humanos , Hidrocortisona/sangre , Periodo Intraoperatorio , Masculino , Persona de Mediana Edad , Radioinmunoensayo , Ratas
18.
Toxicol Lett ; 58(2): 225-30, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1949081

RESUMEN

No studies exist on sister-chromatid exchange (SCE) formation in chagasic patients therapeutically exposed to nifurtimox (NFX) or benznidazol (BZ). In the present study SCE was analyzed in cultures of peripheral lymphocytes of patients aged 11 months to 11 years treated with NFX 12-15 mg/kg/d for 60 days or with BZ 5 mg/kg/d for 30 days. Chagasic patients before treatment constituted a control group. A mean of 30 metaphases were examined for each individual. All treated patients compared with untreated controls did not show a significant increase in SCE frequency. Compared with the percentage of chromosomal aberrations in these patients and others belonging to the same epidemic protocol, SCE seems to be less sensitive in the detection of lymphocyte chromosomal damage caused by NFX or BZ.


Asunto(s)
Enfermedad de Chagas/tratamiento farmacológico , Cromosomas/efectos de los fármacos , Linfocitos/fisiología , Nifurtimox/efectos adversos , Nitroimidazoles/efectos adversos , Intercambio de Cromátides Hermanas/efectos de los fármacos , Tripanocidas/efectos adversos , Enfermedad de Chagas/sangre , Enfermedad de Chagas/genética , Niño , Preescolar , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Linfocitos/efectos de los fármacos , Masculino , Nifurtimox/uso terapéutico , Nitroimidazoles/uso terapéutico , Tripanocidas/uso terapéutico
19.
Arch Dis Child Fetal Neonatal Ed ; 70(2): F147-9; discussion 149-50, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7802758

RESUMEN

The management of neonates with mild hydronephrosis diagnosed antenatally is still debated. Although some of these infants are normal, it is recognised that others will have mild obstruction of the ureteropelvic junction or vesicoureteric reflux (VUR). A prospective study was performed in all newborn infants with an antenatal diagnosis of mild hydronephrosis (47 babies, 62 kidneys) born over a two year period in order to assess the frequency of VUR. Voiding cystography in 14 patients with 21 renal units showed VUR. Two patients underwent surgery and the VUR resolved; the other 12 received medical treatment. Repeat cystography was scheduled for 12-18 months later, when a high rate of spontaneous cure was observed. The remaining patients were monitored by ultrasonography but only in one case did hydronephrosis deteriorate because of the presence of severe ureteropelvic junction obstruction. It is concluded that mild dilatation of the pelvis might be an expression of a potentially severe malformation such as VUR, and a careful follow up of these cases is mandatory.


Asunto(s)
Enfermedades Fetales/diagnóstico por imagen , Hidronefrosis/diagnóstico por imagen , Ultrasonografía Prenatal , Reflujo Vesicoureteral/diagnóstico por imagen , Femenino , Humanos , Hidronefrosis/etiología , Recién Nacido , Masculino , Embarazo , Diagnóstico Prenatal , Estudios Prospectivos , Radiografía , Vejiga Urinaria/diagnóstico por imagen , Reflujo Vesicoureteral/complicaciones
20.
Mutat Res ; 206(2): 217-20, 1988 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3140001

RESUMEN

Chromosomal aberrations and induction of micronuclei were analyzed from cultures of peripheral lymphocytes in 2 groups of chagasic children, before and after treatment with benznidazole. The median incidence of micronucleated interphase lymphocytes (20 patients) and chromosomal aberrations (10 patients) increased from control values of 5/1000 and 3% to 11.5/1000 and 6%, respectively, at a significance of P = 0.05.


Asunto(s)
Enfermedad de Chagas/tratamiento farmacológico , Aberraciones Cromosómicas , Daño del ADN , Mutágenos/efectos adversos , Nitroimidazoles/efectos adversos , Tripanocidas/efectos adversos , Núcleo Celular/efectos de los fármacos , Enfermedad de Chagas/genética , Niño , Preescolar , Femenino , Humanos , Lactante , Linfocitos/citología , Linfocitos/efectos de los fármacos , Masculino , Nitroimidazoles/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA